Allovir, INC Form 4 insider transactions

Director Juan Vera acquired 35,000 Restricted Stock Units (RSUs) in Allovir, Inc., according to a recent SEC Form 4 filing.

Director Shawn Tomasello acquired 35,000 Restricted Stock Units (RSUs) in Allovir, Inc. on June 6, 2024, according to a Form 4 filing.

Allovir's CEO, Diana Brainard, sold shares of common stock on May 21, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Brett R. Hagen, Chief Accounting Officer of Allovir, Inc., sold 541 shares of common stock on May 17, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Vikas Sinha, President and CFO of Allovir, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Edward Miller, General Counsel of Allovir Inc., sold 420 shares of common stock on May 17, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold shares of common stock on May 3, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Brett R. Hagen, Chief Accounting Officer of Allovir, Inc., reports the sale of 1,597 shares of common stock on May 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Vikas Sinha, President and CFO of Allovir, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Edward Miller, General Counsel of Allovir, Inc., sold 2,311 shares of common stock on May 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Brett Hagen, Chief Accounting Officer of Allovir, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Edward Miller, General Counsel of Allovir Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Vikas Sinha, a director, 10% owner, and officer of Allovir, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Edward Miller, General Counsel of Allovir, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

Allovir's CEO, Diana Brainard, sold 1,533 shares of common stock on April 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Brett R. Hagen, Chief Accounting Officer of Allovir, Inc., sold 281 shares of common stock on April 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Vikas Sinha, a director and officer of Allovir, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.